Yatharth Hospitals Q2 FY27 Results and Advent Capital Infusion
Yatharth Hospital & Trauma Care Services Ltd · Press Release · 03 Nov 2026, 7:39 pm
Yatharth Hospitals Q2 FY27 Results and Advent Capital Infusion Yatharth Hospital reported robust Q2 FY27 results, with revenue rising 52% YoY to Rs 4,314 mn and EBITDA increasing 50% YoY to Rs 1,020 mn (margin at 23.6%; adjusted EBITDA margin at 28%). PAT grew 17% YoY to Rs 485 mn, while ARPOB reached Rs 35,948 (+11% YoY). New hospitals contributed 28% of quarterly revenue. Additionally, the company entered a definitive agreement with Advent International for a primary investment of Rs 3,150 crore (~24.9% stake upon full conversion) to fund network expansion towards 7,000–8,000 beds.
Original exchange filing (PDF)
More announcements from Yatharth Hospital & Trauma Care Services Ltd
- We hereby submit Earnings Call Transcript Q2FY27. · 13 Nov 2026
- We hereby submit intimation regarding the Approval of CCI for the proposed Preferential Issue. · 12 Nov 2026
- We hereby submit Monitoring Agency Report for the quarter ended September 30, 2026 (IPO). · 05 Nov 2026
- We hereby submit Earnings Call Recording for Q2FY27. · 04 Nov 2026
- We hereby submit Investor''s Presentation for Q2FY27. · 03 Nov 2026
- We hereby submit Unaudited Financial Results for the second quarter and half year ended September 30, 2026. · 03 Nov 2026
- We hereby submit Outcome of the Board Meeting of the Company held on today. i.e. November 03, 2026. · 03 Nov 2026
- We hereby submit Outcome of the Board Meeting of the Company held on today. i.e. November 03, 2026. · 03 Nov 2026
All Yatharth Hospital & Trauma Care Services Ltd announcements
